|Day Low/High||83.35 / 84.63|
|52 Wk Low/High||71.90 / 106.27|
Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.
One drug distribution executive appearing before a House Committee to answer for shipping millions of doses of opioids into West Virginia apologized and another said his company had a hand in the crisis.
Cardinal Health had its worst day of trading in 14 years.
An internal review of management behavior at the healthcare company over opioid distribution prompted by complaints from shareholder International Brotherhood of Teamsters gives company officials a clean bill of health.
A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.
While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.
McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.
The rumors are coming in hot and heavy on possible moves Walmart and Target are making to keep at Amazon at bay. Meanwhile, stocks just closed below this key point. Rejoice, bears.
One analyst cited 'the stability of retail' as a safe harbor for Walgreens.
President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.
AmerisourceBergen Corporation (NYSE: ABC) today announced that it will present at the Barclays Global Healthcare Conference at 2:05 p.
As further consolidation in the industry comes back into focus, stocks are teetering.
Amazon must move soon to acquire a key healthcare franchise before it misses out completely on rich opportunities or pays too much. Goldman Sachs is scared about markets in 2019.
A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.
A fresh look at the charts and indicators of ABC seems timely.
The most recent short interest data has been released for the 02/15/2018 settlement date, which shows a 2,644,531 share decrease in total short interest for AmerisourceBergen Corp. , to 4,897,883, a decrease of 35.06% since 01/31/2018.
After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.
Walgreens and AmerisourceBergen are talking about a deal.
Stocks ended higher on Tuesday.
Should Walgreens really buy the rest of AmerisourceBergen that it doesn't already own? Analysts seem conflicted.
The Wall Street Journal reported that Walgreens Boots Alliance has contacted AmerisourceBergen about a possible takeover.
Wall Street futures were down Tuesday as the dollar saw modest losses against most major currencies.
With Dow futures pointed south, it looks to be another interesting day on Wall Street. Here's what you need to know.
U.S. stock futures are under pressure on Tuesday, following strong gains on Monday that saw the Dow Jones Industrial Average rise more than 400 points.
Walgreens approached Amerisource last week, according to a published report.
As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.